NO942323L - Soyaprotein eller hydrolysater i farmasöytiske preparater for beskyttelse av bioaktive peptider mot enzymatisk inaktivering - Google Patents

Soyaprotein eller hydrolysater i farmasöytiske preparater for beskyttelse av bioaktive peptider mot enzymatisk inaktivering

Info

Publication number
NO942323L
NO942323L NO942323A NO942323A NO942323L NO 942323 L NO942323 L NO 942323L NO 942323 A NO942323 A NO 942323A NO 942323 A NO942323 A NO 942323A NO 942323 L NO942323 L NO 942323L
Authority
NO
Norway
Prior art keywords
hydrolysates
protection
pharmaceutical compositions
enzymatic inactivation
soy protein
Prior art date
Application number
NO942323A
Other languages
English (en)
Norwegian (no)
Other versions
NO942323D0 (no
Inventor
Gordon L Amidon
Glen D Leesman
Patrick J Sinko
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO942323D0 publication Critical patent/NO942323D0/no
Publication of NO942323L publication Critical patent/NO942323L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2207—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Botany (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NO942323A 1991-12-18 1994-06-17 Soyaprotein eller hydrolysater i farmasöytiske preparater for beskyttelse av bioaktive peptider mot enzymatisk inaktivering NO942323L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81059391A 1991-12-18 1991-12-18
PCT/US1992/009336 WO1993011799A1 (en) 1991-12-18 1992-11-09 Soybean protein or hydrolyzates in pharmaceutical compositions to protect bioactive peptides from enzymatic inactivation

Publications (2)

Publication Number Publication Date
NO942323D0 NO942323D0 (no) 1994-06-17
NO942323L true NO942323L (no) 1994-06-17

Family

ID=25204183

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942323A NO942323L (no) 1991-12-18 1994-06-17 Soyaprotein eller hydrolysater i farmasöytiske preparater for beskyttelse av bioaktive peptider mot enzymatisk inaktivering

Country Status (12)

Country Link
EP (1) EP0617626A1 (pt)
JP (1) JPH06510796A (pt)
AU (1) AU3058392A (pt)
CA (1) CA2125400A1 (pt)
FI (1) FI942938L (pt)
HU (1) HUT69785A (pt)
IL (1) IL104048A0 (pt)
MX (1) MX9207407A (pt)
NO (1) NO942323L (pt)
PT (1) PT101135A (pt)
WO (1) WO1993011799A1 (pt)
ZA (1) ZA929761B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994007472A1 (en) * 1992-10-02 1994-04-14 Pfizer Inc. Pharmaceutical compositions containing nonionic surfactants
AU7273494A (en) * 1993-09-01 1995-03-22 Pfizer Inc. Pharmaceutical compositions containing anionic surfactants
DE19530865A1 (de) * 1995-08-22 1997-02-27 Michael Dr Med Nauck Wirkstoff sowie Mittel zur parenteralen Ernährung
US6852690B1 (en) 1995-08-22 2005-02-08 Amylin Pharmaceuticals, Inc. Method and composition for enhanced parenteral nutrition
ATE337712T1 (de) * 2000-01-27 2006-09-15 Peros Systemes Technologies In Zusammensetzung zur intestinalen verabreichung
GB0015921D0 (en) * 2000-06-30 2000-08-23 Nat Biolog Standards Board Improvements in or relating to stabilisation of substances
CL2008001640A1 (es) * 2007-06-08 2008-11-07 Bergen Teknologioverforing As Uso de hidroxiprolina para preparar una composicion de alemento destinada a promover el crecimiento de un animal, como peces, aves y mamiferos.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537769A (en) * 1982-04-06 1985-08-27 American Cyanamid Company Stabilization of influenza virus vaccine
IL68769A (en) * 1983-05-23 1986-02-28 Hadassah Med Org Pharmaceutical compositions containing insulin for oral administration
US4774089A (en) * 1985-06-14 1988-09-27 Albion International, Inc. Stimulation of gonadotropic hormones with mineral mixtures containing amino acid chelates
MY103189A (en) * 1986-10-31 1993-05-29 Pfizer Nor-statine and nor-cyclostatine polypeptides
ES2061688T3 (es) * 1987-11-13 1994-12-16 Smithkline Beecham Farma Composiciones farmaceuticas que comprenden una calcitonina y un glicirricinato como mejorador de la absorcion.
IL90244A (en) * 1988-05-11 1993-05-13 Du Pont Merck Pharma Peptide-drug compositions, for buccal and nasal administration, containing :-aminoboronic acid derivatives
DD273980B5 (de) * 1988-07-12 1994-04-14 Berlin Chemie Ag Verfahren zur Herstellung von Insulin-Pr{paraten zur rektalen Anwendung
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
DK546289D0 (da) * 1989-11-02 1989-11-02 Danochemo As Carotenoidpulvere

Also Published As

Publication number Publication date
FI942938A7 (fi) 1994-06-17
NO942323D0 (no) 1994-06-17
HUT69785A (en) 1995-09-28
JPH06510796A (ja) 1994-12-01
WO1993011799A1 (en) 1993-06-24
IL104048A0 (en) 1993-05-13
AU3058392A (en) 1993-07-19
CA2125400A1 (en) 1993-06-24
PT101135A (pt) 1994-03-31
EP0617626A1 (en) 1994-10-05
FI942938A0 (fi) 1994-06-17
FI942938L (fi) 1994-06-17
HU9401824D0 (en) 1994-09-28
MX9207407A (es) 1993-06-01
ZA929761B (en) 1994-06-17

Similar Documents

Publication Publication Date Title
ES2178000T3 (es) Composiciones y metodos para tratar infecciones usando analogos de indolicidina.
BR0108402A (pt) Análogos de nucleosìdeo com base monocìclica carboxamidina modificado
BR0112666A (pt) Peptìdeos como inibidores de ns3-serina protease de vìrus da hepatite c
AU6020099A (en) Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
WO1997049373A3 (en) Treatment and prevention of hiv infection by administration of derivatives of human chorionic gonadotropin
CY1106769T1 (el) Λυοφιλοποιησιμη φαρμακευτικη συνθεση εικονικου φαρμακου προοριζομενη για τη μιμηση ενος φαρμακου, ειδικα με βαση πρωτεϊνες ή πολυπεπτιδια
DE69532996D1 (de) Peptidanaloge des menschlichen basischen myelinproteins
ATE435661T1 (de) Adjuvant qs-21 enthaltende zusammensetzungen mit polysorbate oder cyclodextrin als hilfsmittel
FR2792202B1 (fr) Extrait peptidique de lupin et composition pharmaceutique ou cosmetique ou nutraceutique comprenant un tel extrait
NO20010995D0 (no) Cytotoksiske peptider modifisert med store eller lipofile rester
DE69937798D1 (de) Peptide, basierend auf der sequenz des menschlichen lactoferrins und ihre anwendung
ATE144535T1 (de) Plättchen blockierende peptide
SE0002202D0 (sv) New peptides
PL371549A1 (en) Tolerogenic peptides from myelin basic protein
WO2004054607A3 (de) Stabile therapeutische proteine
ATE234111T1 (de) Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung
ATE213499T1 (de) Peptidanaloge des menschlichen, basischen myelinproteins mit substitution an position 91 zur behandlung der multiplen sklerose
DK1079849T3 (da) Anvendelse af HMG-proteiner til fremstilling af lægemidler med cytotoksisk virkning
NO942323L (no) Soyaprotein eller hydrolysater i farmasöytiske preparater for beskyttelse av bioaktive peptider mot enzymatisk inaktivering
CO5570658A2 (es) Composicion y metodo para el tratamiento de la diabetes
ATE359296T1 (de) Pharmazeutische peptide formulierungen zur behandlung von staubmilben allergie
RU96120655A (ru) Композиция для профилактики и лечения гриппа и орви
FR2569111B1 (fr) Nouveaux medicaments contenant des tripeptides
EP1174439A3 (en) Compositions and methods for treating infections using analogues of indolicidin
NZ228208A (en) Eglin compounds (hurudin) and protease inhibitor pharmaceutical compositions